Infection Innovation Consortium
The Infection Innovation Consortium (iiCON) has established a leading global centre for infectious disease R&D in the North West of England. Designed to support co-innovation, the £173.5 million programme bridges the gap between industry, academics, and clinicians to accelerate the discovery and development of new treatments for patients and communities. iiCON provides industry with access to world-class expertise, facilities, and resources – supporting companies of all sizes, from early-stage start-ups to global pharma leaders, at every stage of the innovation journey from discovery to adoption.
Pembroke House will provide a bespoke future-focused centre to support iiCON’s work driving forward collaborative innovation at all levels. The centre will act as a catalyst to strengthen partnership working, bringing forward transformative technologies that will bolster the global response to infectious disease and strengthen pandemic resilience.